PEPTIMED INC has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in Australia, EPO (European Patent Office) and Singapore. Its main competitors in its focus markets pharmaceuticals and biotechnology are BAVARIAN NORDIC INC, LIGOCYTE PHARMACEUTICALS INC and ENGENEIC MOLECULAR DELIVERY PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Singapore | 4 | |
#4 | Canada | 3 | |
#5 | Brazil | 2 | |
#6 | Japan | 2 | |
#7 | Republic of Korea | 2 | |
#8 | United States | 2 | |
#9 | China | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Primiano Thomas | 22 |
#2 | Chang Bey-Dih | 21 |
#3 | Heidel Jeremy | 12 |
#4 | Bookbinder Lonnie | 5 |
#5 | Thomas Primiano | 3 |
#6 | Jeremy Heidel | 3 |
#7 | Bey-Dih Chang | 2 |
#8 | Chang Bey Dih | 2 |
#9 | Lonnie Bookbinder | 1 |
Publication | Filing date | Title |
---|---|---|
CN106714811A | Anti-tumor compositions and methods | |
SG190088A1 | Compositions of a peptide targeting system for treating cancer | |
EP3190187A1 | Reagents and methods for treating cancer |